Rex Bionics (Rex Bionics) Net Margin % : 0.00% (As of Mar. 2018)

View and export this data going back to 2015. Start your Free Trial

What is Rex Bionics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Rex Bionics's Net Income for the six months ended in Mar. 2018 was $0.00 Mil. Rex Bionics's Revenue for the six months ended in Mar. 2018 was $0.00 Mil. Therefore, Rex Bionics's net margin for the quarter that ended in Mar. 2018 was 0.00%.

The historical rank and industry rank for Rex Bionics's Net Margin % or its related term are showing as below:

RXRBY' s Net Margin % Range Over the Past 10 Years
Min: -1830.16 Med: -1830.16 Max: -1830.16
Current: -1830.16

RXRBY's Net Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -0.485 vs RXRBY: -1830.16

Rex Bionics Net Margin % Historical Data

The historical data trend for Rex Bionics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rex Bionics Net Margin % Chart

Rex Bionics Annual Data

Trend

Nov13

Mar16

Mar17

Mar18

Net Margin %

-1,830.11

Rex Bionics Semi-Annual Data
	May13	Nov13	May14	Sep15	Mar16	Sep16	Mar17	Mar18
Net Margin %	Get a 7-Day Free Trial			-1,187.94	1,462.98	-1,345.74	5,146.28	-

Competitive Comparison of Rex Bionics's Net Margin %

For the Medical Devices subindustry, Rex Bionics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rex Bionics's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rex Bionics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Rex Bionics's Net Margin % falls into.

Rex Bionics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Rex Bionics's Net Margin for the fiscal year that ended in Mar. 2018 is calculated as

Net Margin	=	Net Income (A: Mar. 2018 )	/	Revenue (A: Mar. 2018 )
	=	-3.221	/	0.176
	=	-1,830.11 %

Rex Bionics's Net Margin for the quarter that ended in Mar. 2018 is calculated as

Net Margin	=	Net Income (Q: Mar. 2018 )	/	Revenue (Q: Mar. 2018 )
	=	0	/	0
	=	%

Rex Bionics (OTCPK:RXRBY) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Rex Bionics Net Margin % Related Terms

Thank you for viewing the detailed overview of Rex Bionics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rex Bionics (Rex Bionics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rex Bionics PLC (OTCPK:RXRBY) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.rexbionics.com

Rex Bionics PLC, formerly known as Union MedTech PLC, was incorporated and domiciled in england and Wales on February 27, 2012. The Company is engaged in the research & development, manufacturing and commercialisation of robotic devices designed to provide physiotherapy to and improve the physical and psychological well-being of people with mobility impairment as a result of spinal cord injury or other neurological damage. It provides independent mobility to wheelchair users and other mobility impaired persons using robotic technology, custom-designed electromechanical actuators, precision engineering, and specialised networking systems.The Company's REX devices are REX Rehab and REX Personal.

Rex Bionics (Rex Bionics) Headlines

No Headlines